GSK ▼ -4.3% - GSK plc $GSK Q3 2026 Earnings - Revenue: £8.89B (est £8.86B) - Adj EPS: 54.6p (est 50.3p) - Shingrix Revenue: £780M (est £855.9M) - Vaccines Sales: £2.58B (est £2.64B) - Arexvy Revenue: £195M (est £225.8M) - Dividend/Share: 17p (est 17p) 28-OCT-2026 05:17 AM ET